中华泌尿外科杂志2024,Vol.45Issue(8) :641-644.DOI:10.3760/cma.j.cn112330-20230825-00055

原发性前列腺印戒细胞癌的诊疗进展

Progress in diagnosis and treatment of primary prostatic signet ring cell carcinoma

王浩 谢大炜 王思琦 李馨 杨朴深 何威峰 王建文
中华泌尿外科杂志2024,Vol.45Issue(8) :641-644.DOI:10.3760/cma.j.cn112330-20230825-00055

原发性前列腺印戒细胞癌的诊疗进展

Progress in diagnosis and treatment of primary prostatic signet ring cell carcinoma

王浩 1谢大炜 1王思琦 1李馨 1杨朴深 1何威峰 1王建文1
扫码查看

作者信息

  • 1. 首都医科大学附属北京朝阳医院泌尿外科,北京 100020
  • 折叠

摘要

原发性前列腺印戒细胞癌(PPSRCC)是男性泌尿生殖系统中极为罕见的恶性肿瘤之一,诊断主要依靠病理组织学和免疫组化染色检查.PPSRCC的侵袭性强、治疗反应较低、预后较差.本文概述PPSRCC发生机制、临床表现、病理学特点、诊断、治疗和预后方面的研究进展.

Abstract

Primary prostate signet ring cell carcinoma(PPSRCC)is one of the extremely rare malignant tumors in the male urogenital system,and its diagnosis mainly relies on pathological and immunohistochemical examination.Compared with typical prostate cancer,PPSRCC is characterized by more aggressive with less treatment response and poor prognosis.Current researches on the pathogenesis,clinical manifestations,pathological characteristics,diagnosis,treatment and prognosis of PPSRCC were reviewed.

关键词

前列腺肿瘤//印戒细胞

Key words

Prostatic neoplasms/Carcinoma/Signet ring cell

引用本文复制引用

基金项目

首都卫生发展科研专项项目(首发2020-2-2033)

出版年

2024
中华泌尿外科杂志
中华医学会

中华泌尿外科杂志

CSTPCDCSCD北大核心
影响因子:1.628
ISSN:1000-6702
参考文献量36
段落导航相关论文